News
Market and company headlines
The fair value estimate for Molson Coors Beverage has been revised from US$45.24 to US$43.81, which marks a modest reset in the analyst model for the stock. This adjustment lines up with Street research that has been edging price targets lower as analysts weigh softer earnings previews against a still defensive profile for consumer staples. As you read on, you will see how this shift in targets fits into the evolving Molson Coors narrative and what to watch next. Stay updated as the Fair...

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Income investors screen for yield, but a dividend is only as durable as the cash flow behind it. Three big consumer brands currently flash warning signs that go beyond a single quarter of weakness: a suspended payout hiding behind stale screen data, a beer giant guiding double-digit earnings declines into its dividend, and a motorcycle […]
Heineken’s US chief executive Maggie Timoney went on Bloomberg this week to explain why Serena Williams was named the first global ambassador for Heineken 0.0 while simultaneously fronting a GLP-1 weight-loss brand, the drug class investors have blamed for suppressing alcohol demand. Her answer: “studies show that people who are on GLP1s also drink alcohol. […]
Molson Coors Beverage Company (TAP) Barclays 19th Annual Global Consumer Staples Conference September 9, 2026 1:30 PM EDTCompany ParticipantsRahul Goyal -...

Illumina stock is joining the S&P 500 on Sept. 21. Here's why that matters, what's fueling growth, and what investors should watch next.
Everpure stock is joining the S&P 500 on Sept. 21. Here's what's changing, why it matters, and what's driving Everpure's growth this year.
Shares of Bloom Energy are surging on the news that the company is set to join the S&P 500.
Amgen falls following Swiss drugmaker Novartis’ disappointing trial data. Novartis trades sharply lower.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Molson Coors (NYSE:TAP) and its peers.

CEO Goyal warns geopolitical tensions and inflation pressured volume and margins.

JP Morgan analyst Drew Levine maintains Molson Coors Beverage (NYSE:TAP) with a Neutral and raises the price target from $41 to $42.

Beer company Molson Coors (NYSE:TAP) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 3.3% year on year to $3.10 billion. Its non-GAAP profit of $1.58 per share was 4.4% above analysts’ consensus estimates.

UBS analyst Peter Grom maintains Molson Coors Beverage (NYSE:TAP) with a Neutral and raises the price target from $40 to $45.

TAP beats Q2 estimates as pricing and cost savings offset weaker volumes, while management reaffirms its 2026 outlook.
